Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
The pharmaceutical landscape is constantly evolving, driven by a continuous pursuit of more effective and targeted therapies. At NINGBO INNO PHARMCHEM CO.,LTD., we are at the forefront of supporting these innovations by providing critical chemical intermediates, such as 3-(4-Phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine (CAS 330786-24-8). This compound is fundamental to the synthesis of Ibrutinib, a pivotal drug in modern oncology that has transformed the treatment of several challenging cancers by targeting the Bruton's tyrosine kinase (BTK) pathway.
The development of targeted therapies like Ibrutinib relies heavily on the precise and efficient synthesis of complex molecular structures. 3-(4-Phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine serves as a key building block, enabling chemists to assemble the final drug molecule with high specificity and yield. The stringent purity requirements, often exceeding 98%, for such pharmaceutical intermediates underscore the importance of advanced chemical manufacturing processes. NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to mastering these processes, ensuring our clients receive intermediates that meet the highest industry standards.
The role of this compound as a BTK inhibitor synthesis intermediate highlights its significance in the realm of precision medicine. By inhibiting the BTK enzyme, Ibrutinib effectively disrupts signaling pathways critical for the growth and survival of certain cancer cells. The reliable supply of the Ibrutinib intermediate CAS 330786-24-8 directly supports the ongoing research and large-scale production efforts needed to make these advanced treatments accessible to patients. This is why our focus on the detailed 3-(4-Phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine synthesis is so crucial.
NINGBO INNO PHARMCHEM CO.,LTD. is more than just a supplier; we aim to be a partner in innovation. By providing high-quality organic synthesis intermediates for cancer drugs and supporting the pharmaceutical production of Ibrutinib, we contribute to the advancements that improve patient outcomes. Our commitment to excellence ensures that the chemical foundations of these life-saving drugs are robust and reliable, enabling further breakthroughs in medical science.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
